BPC-157 in a Rat Incisional-Pain Model: Study Summary
Researchers evaluated behavioural responses after BPC-157 administration in rats subjected to a standardised hind-paw incision model.
Study design
Sprague-Dawley rats were assigned to saline, three BPC-157 dose groups or morphine. Mechanical withdrawal thresholds were measured after incision, and a formalin test was used to examine early and later flinching responses.
What the researchers reported
The BPC-157 groups showed higher mechanical thresholds at selected early measurements and at day four. In the formalin test, flinching decreased during phase one but not phase two. The authors characterised the observed antinociceptive effect as short-lived.
What this result does not establish
This was an animal pain-behaviour experiment, not a human clinical trial. It did not establish a treatment effect, optimal exposure, comparative safety or relevance to human postoperative pain.
This article summarizes one published study about BPC-157. It does not establish clinical efficacy, general safety, regulatory approval or suitability for human use. Findings should be interpreted within the model, methods and limitations of the original paper.
Related research material
Review the corresponding catalogue listing, labelled amount and available documentation. The study may use a different formulation or experimental preparation; it does not verify our product, its batch or suitability for human use.
Our Approach
Evidence before assumption.
TAM Global Research focuses on transparent documentation, careful scientific interpretation and clear distinction between what available evidence supports and what requires further verification.
Explore our quality standards